Faculty of Medicine, University of Seychelles-American Institute of Medicine, Seychelles.
Department of Pharmacies, National Medical Supplies Fund, Sudan.
J Immunol Res. 2020 Nov 5;2020:9475058. doi: 10.1155/2020/9475058. eCollection 2020.
is a common pathogen that is responsible for serious hospital-acquired infections, ventilator-associated pneumonia, and various sepsis syndromes. Also, it is a multidrug-resistant pathogen recognized for its ubiquity and its intrinsically advanced antibiotic-resistant mechanisms. It usually affects immunocompromised individuals but can also infect immunocompetent individuals. There is no vaccine against it available till now. This study predicts an effective epitope-based vaccine against fructose bisphosphate aldolase (FBA) of using immunoinformatics tools. The protein sequences were obtained from NCBI, and prediction tests were undertaken to analyze possible epitopes for B and T cells. Three B cell epitopes passed the antigenicity, accessibility, and hydrophilicity tests. Six MHC I epitopes were found to be promising, while four MHC II epitopes were found promising from the result set. Nineteen epitopes were shared between MHC I and II results. For the population coverage, the epitopes covered 95.62% worldwide excluding certain MHC II alleles. We recommend and studies to prove its effectiveness.
是一种常见的病原体,可导致严重的医院获得性感染、呼吸机相关性肺炎和各种败血症综合征。此外,它还是一种多药耐药病原体,具有普遍性和内在先进的抗生素耐药机制。它通常影响免疫功能低下的个体,但也可以感染免疫功能正常的个体。目前还没有针对它的疫苗。本研究使用免疫信息学工具预测了一种针对果糖-1,6-二磷酸醛缩酶(FBA)的有效基于表位的疫苗。从 NCBI 获得蛋白质序列,并进行预测测试以分析 B 细胞和 T 细胞的可能表位。三个 B 细胞表位通过了抗原性、可及性和亲水性测试。发现六个 MHC I 表位有希望,而从结果集中发现四个 MHC II 表位有希望。19 个表位在 MHC I 和 II 结果之间共享。对于人群覆盖率,表位覆盖了全球 95.62%的人口,不包括某些 MHC II 等位基因。我们建议进行 和 研究以证明其有效性。